UK Endomyocardial Biopsy Market Size & Outlook, 2023-2030
UK endomyocardial biopsy market, 2018-2030 (US$M)
Related Markets
UK endomyocardial biopsy market highlights
- The UK endomyocardial biopsy market generated a revenue of USD 13.9 million in 2023 and is expected to reach USD 21.2 million by 2030.
- The UK market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
- In terms of segment, forceps was the largest revenue generating product in 2023.
- Forceps is the most lucrative product segment registering the fastest growth during the forecast period.
Endomyocardial biopsy market data book summary
| Market revenue in 2023 | USD 13.9 million |
| Market revenue in 2030 | USD 21.2 million |
| Growth rate | 6.2% (CAGR from 2023 to 2030) |
| Largest segment | Forceps |
| Fastest growing segment | Forceps |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Forceps, Accessories |
| Key market players worldwide | Argon Medical Devices, Terumo Corp, Cardinal Health Inc, Scholten Surgical Instruments, Changzhou Lookmed Medical Instrument Co., Fehling Instruments |
Other key industry trends
- In terms of revenue, UK accounted for 4.1% of the global endomyocardial biopsy market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany endomyocardial biopsy market is projected to lead the regional market in terms of revenue in 2030.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 8.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endomyocardial Biopsy Market Scope
Endomyocardial Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK endomyocardial biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endomyocardial biopsy market will help companies and investors design strategic landscapes.
Forceps was the largest segment with a revenue share of 71.94% in 2023. Horizon Databook has segmented the UK endomyocardial biopsy market based on forceps, accessories covering the revenue growth of each sub-segment from 2018 to 2030.
Coronary heart disease is a major cause of death in the UK, with a significant number of deaths each year attributed to heart and circulatory diseases. CVD accounts for 37% of female and 38% of male deaths in the country, resulting in the premature death of 42,000 patients annually.
The incidence and prevalence of CVD are rising due to several risk factors such as high cholesterol levels, familial hypercholesterolemia, & lifestyle-related factors including smoking, high alcohol intake, fatty diets, & lack of physical activity. Therefore, such factors are expected to boost the market.
Reasons to subscribe to UK endomyocardial biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK endomyocardial biopsy market databook
-
Our clientele includes a mix of endomyocardial biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK endomyocardial biopsy market , including forecasts for subscribers. This country databook contains high-level insights into UK endomyocardial biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK endomyocardial biopsy market size, by product, 2018-2030 (US$M)
UK Endomyocardial Biopsy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
